Wei Bai

3.3k total citations
39 papers, 1.2k citations indexed

About

Wei Bai is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Wei Bai has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 13 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Wei Bai's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease and Transplantation (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Wei Bai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease and Transplantation (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Wei Bai collaborates with scholars based in China, United States and Germany. Wei Bai's co-authors include Yuqin Ye, Yongxiang Yang, Xiaosheng He, Xinhong Su, Jun He, Guohong Han, Yan Zhao, Zhanxin Yin, Daiming Fan and Xin Zhang and has published in prestigious journals such as Hepatology, Stroke and Scientific Reports.

In The Last Decade

Wei Bai

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Bai China 22 496 439 329 238 234 39 1.2k
Xiao Lin China 16 178 0.4× 401 0.9× 253 0.8× 105 0.4× 155 0.7× 39 869
Yunosuke Nishihara Japan 24 547 1.1× 209 0.5× 425 1.3× 590 2.5× 170 0.7× 55 1.6k
Léa Mirian Barbosa da Fonseca Brazil 18 142 0.3× 236 0.5× 154 0.5× 326 1.4× 129 0.6× 63 1.3k
Maria Ausiliatrice Puglisi Italy 18 102 0.2× 459 1.0× 83 0.3× 443 1.9× 268 1.1× 38 1.5k
Gao‐Jun Teng China 18 268 0.5× 140 0.3× 123 0.4× 214 0.9× 68 0.3× 45 928
Steffen Albrecht Canada 23 102 0.2× 709 1.6× 192 0.6× 322 1.4× 158 0.7× 56 1.8k
Eisuke Ozawa Japan 16 165 0.3× 128 0.3× 166 0.5× 205 0.9× 75 0.3× 62 1.1k
Masato Narita Japan 22 565 1.1× 334 0.8× 341 1.0× 360 1.5× 132 0.6× 74 1.4k
Melina Nieminen-Kelhä Germany 23 51 0.1× 597 1.4× 149 0.5× 591 2.5× 89 0.4× 63 2.1k
Uzma Samadani United States 20 79 0.2× 583 1.3× 213 0.6× 607 2.6× 60 0.3× 39 1.7k

Countries citing papers authored by Wei Bai

Since Specialization
Citations

This map shows the geographic impact of Wei Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Bai more than expected).

Fields of papers citing papers by Wei Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Bai. The network helps show where Wei Bai may publish in the future.

Co-authorship network of co-authors of Wei Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Bai. A scholar is included among the top collaborators of Wei Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Bai. Wei Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Yong, Qiuhe Wang, Bohan Luo, et al.. (2024). Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding. Journal of Hepatology. 82(2). 245–257. 5 indexed citations
2.
Xia, Dongdong, et al.. (2024). Tumor burden affects the progression pattern on the prognosis in patients treated with sorafenib. Frontiers in Oncology. 14. 1405178–1405178. 1 indexed citations
3.
Bai, Wei, et al.. (2023). Case report: mitochondrial diabetes mellitus in a Chinese family due to m.3243A>G. Journal of Pediatric Endocrinology and Metabolism. 36(8). 777–781. 1 indexed citations
4.
5.
Ye, Yuqin, et al.. (2022). HBO Alleviates Neural Stem Cell Pyroptosis via lncRNA‐H19/miR‐423‐5p/NLRP3 Axis and Improves Neurogenesis after Oxygen Glucose Deprivation. Oxidative Medicine and Cellular Longevity. 2022(1). 9030771–9030771. 23 indexed citations
6.
Lv, Yong, Hui Chen, Bohan Luo, et al.. (2022). Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial. ˜The œLancet. Gastroenterology & hepatology. 7(8). 736–746. 26 indexed citations
7.
Li, Kai, Yong Lv, Qiuhe Wang, et al.. (2022). Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS. JHEP Reports. 4(5). 100448–100448. 25 indexed citations
8.
Bai, Wei, Xin Zhang, Xinhong Su, et al.. (2020). [Activation of miR-124-3p/Notch pathway promotes proliferation and differentiation of rat neural stem cells after traumatic brain injury].. PubMed. 36(1). 49–55. 2 indexed citations
9.
10.
Meng, Xin, Minjuan Zheng, Ming Yu, et al.. (2019). Transplantation of CRISPRa system engineered IL10-overexpressing bone marrow-derived mesenchymal stem cells for the treatment of myocardial infarction in diabetic mice. Journal of Biological Engineering. 13(1). 49–49. 40 indexed citations
11.
Su, Xinhong, Yuqin Ye, Yongxiang Yang, et al.. (2019). The Effect of SPTLC2 on Promoting Neuronal Apoptosis is Alleviated by MiR-124-3p Through TLR4 Signalling Pathway. Neurochemical Research. 44(9). 2113–2122. 6 indexed citations
12.
Zhao, Zi‐Ai, Yan Zhao, Nan Yang, et al.. (2017). Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation. Translational Psychiatry. 7(5). e1123–e1123. 38 indexed citations
13.
Zhao, Yan, Rafael Durán, Wei Bai, et al.. (2017). Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?. CardioVascular and Interventional Radiology. 41(3). 433–442. 24 indexed citations
14.
Yang, Yongxiang, Yuqin Ye, Xinhong Su, et al.. (2017). MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury. Frontiers in Cellular Neuroscience. 11. 55–55. 193 indexed citations
15.
Liu, Lei, Yan Zhao, Jia Jia, et al.. (2016). The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization. Scientific Reports. 6(1). 19851–19851. 37 indexed citations
16.
Zhou, Chunxiang, Wei Bai, Zhigang Xu, et al.. (2015). Protective effect of crocetin against burn-induced intestinal injury. Journal of Surgical Research. 198(1). 99–107. 25 indexed citations
17.
Liu, Lei, Hui Chen, Yan Zhao, et al.. (2014). EASL- and mRECIST-Evaluated Responses to Combination Therapy of Sorafenib with Transarterial Chemoembolization Predict Survival in Patients with Hepatocellular Carcinoma. Clinical Cancer Research. 20(6). 1623–1631. 22 indexed citations
18.
Ma, Wenhui, Jia Jia, Shengjun Wang, et al.. (2014). The Prognostic Value of 18F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE). Theranostics. 4(7). 736–744. 28 indexed citations
19.
20.
Qi, Xingshun, Cheng Zhang, Guohong Han, et al.. (2011). Prevalence of the JAK2V617F mutation in Chinese patients with Budd‐Chiari syndrome and portal vein thrombosis: A prospective study. Journal of Gastroenterology and Hepatology. 27(6). 1036–1043. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao Lin Breakdown of academic impact, for papers by Yunosuke Nishihara Breakdown of academic impact, for papers by Léa Mirian Barbosa da Fonseca Breakdown of academic impact, for papers by Maria Ausiliatrice Puglisi Breakdown of academic impact, for papers by Gao‐Jun Teng Breakdown of academic impact, for papers by Steffen Albrecht Breakdown of academic impact, for papers by Eisuke Ozawa Breakdown of academic impact, for papers by Masato Narita Breakdown of academic impact, for papers by Melina Nieminen-Kelhä Breakdown of academic impact, for papers by Uzma Samadani
Rankless by CCL
2026